Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans

Journal of Cerebral Blood Flow and Metabolism

Volumn 28, Issue 2, 2008, Pages 395-401

  Sachse, Kathleen T ^a,b   Jackson, Edwin K ^b   Wisniewski, Stephen R ^b   Gillespie, Delbert G ^b   Puccio, Ava M ^b   Clark, Robert S B ^a,b   Dixon, C Edward ^a,b   Kochanek, Patrick M ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Alcohol; Coffee; Head injury; Head trauma; Theobromine

Indexed keywords

CAFFEINE; PARAXANTHINE; THEOBROMINE; THEOPHYLLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRAUMATIC BRAIN INJURY; ULTRAVIOLET RADIATION;

ADULT; AGING; BRAIN INJURIES; CAFFEINE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; ETHANOL; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMANS; MALE; PROSPECTIVE STUDIES; THEOBROMINE; THEOPHYLLINE; TREATMENT OUTCOME;

EID: 38549124582     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600539     Document Type: Article

References (43)

1. Al Moutaery K, Al Deeb S, Ahmad Khan H, Tariq M (2003) Caffeine impairs short-term neurological outcome after concussive head injury in rats. Neurosurgery 53:704-12
2. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production. Neuroscience 142:941-52
3. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC (2001) Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50:56-63
4. Azam S, Hadi N, Khan NU, Hadi SM (2003) Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit 9:BR325-30
5. Bayir H, Marion DW, Puccio AM, Wisniewski SR, Janesko KL, Clark RSB, Kochanek PM (2004) Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma 21:1-8
6. Bell MJ, Robertson CS, Kochanek PM, Goodman JC, Gopinath S, Carcillo JA, Clark RSB, Marion D, Mi Z, Jackson E (2001) Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury. Crit Care Med 29:399-404
7. Boulenger JP, Patel J, Post RM, Parma AM, Marangos PJ (1983) Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci 32:1135-42
8. 2A analogue improves neurologic outcome after spinal cord trauma in the rabbit. J Trauma 53:225-31
9. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Schwarzschild MA (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19:9192-200
10. Clark RSB, Carcillo JA, Kochanek PM, Obrist WD, Jackson EK, Mi Z, Wisniewski SR, Bell MJ, Marion DW (1997) Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 41:1284-93
11. 2B adenosine receptors. J Neurochem 98:616-28
12. Dash PK, Moore AN, Moody MR, Treadwell R, Felix JL, Clifton GL (2004) Post-trauma administration of caffeine plus ethanol reduces contusion volume and improves working memory in rats. J Neurotrauma 21:1573-83
13. 1 receptors in the striatum: different interactions with the dopaminergic system. Eur J Neuroscience 11:3101-14
14. Doppenberg EM, Choi SC, Bullock R (2004) Clinical trials in traumatic brain injury: lessons for the future. J Neurosurg Anesthesiol 16:87-94
15. Evans SM, Griffiths RR (1999) Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. JPET 289:285-94
16. Fredholm BB (1982) Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol Scand 115:283-6
17. Frye RF, Stiff DD, Branch RA (1998) A sensitive method for the simultaneous determination of caffeine and its dimethylxanthine metabolites in human plasma: application to CYP1A2 phenotyping. J Liq Chrom Rel Technol 21:1161-71
18. Georgiev V, Johansson B, Fredholm BB (1993) Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res 612:271-7
19. Guidelines for the management of severe head injury (1996) Introduction. J Neurotrauma 11:643-5
20. 1, receptors mediate the arousal effect of caffeine. Nature Neurosci 8:858-9
21. Jacobson KA, von Lubitz DKJE, Daly JW, Fredholm BB (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. TiPS 17:108-13
22. 2 adenosine receptor binding and on mRNA levels in rat brain. Arch Pharmacol 347:407-14
23. Kochanek PM, Hendrich KS, Jackson EK, Wisniewski SR, Melick JA, Shore PM, Janesko KL, Ho C (2005) Characterization of the effects of adenosine receptor agonists on cerebral blood flow in uninjured and traumatically injured rat brain using continuous arterial spin-labeled magnetic resonance imaging. J Cereb Blood Flow Metab 25:1596-612
24. Kochanek PM, Vagni VA, Janesko KL, Washington C, Crumrine P, Garman RH, Jenkins LW, Clark RSB, Homanics G, Dixon CE, Schnermann J, Jackson EK (2006) Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 26:565-75
25. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156:445-53
26. Nutrition Action Newsletter, Center for Science in the Public Interest (2007). 4 January, http://www.cspinet.org/nah/caffeine/caffeine_corner.htm
27. Pignataro G, Simon RP, Boison D (2007) Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab 27:1-5. E-pub 2006 May 10
28. Phillis JW, Goshgarian HG (2001) Adenosine and neurotrauma: therapeutic perspectives. Neurol Res 23:183-9
29. Pugliese AM, Coppi E, Spalluto G, Corradetti R, Pedata F (2006) A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro. Br J Pharmacol 147:524-32
30. Ramkumar V, Bumgarner JR, Jacobson KA, Stiles GL (1988) Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion. J Clin Invest 82:242-7
31. 2A analogue reduces long-term neurologic injury after blunt spinal trauma. J Surg Res 121:130-4
32. Ribeiro JA (2005) What can adenosine neuromodulation do for neuroprotection? Curr Drug Targets - CNS Neurol Disord 4:325-9
33. Robertson CL, Bell MJ, Kochanek PM, Adelson PD, Ruppel RA, Wisniewski SR, Mi Z, Janesko KL, Clark RSB, Marion DW, Graham SH, Carcillo JA, Jackson EK (2001) Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit Care Med 29:2287-93
34. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung K-H, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674-9
35. Schapira AHV, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Le Novere N, Obeso JA, Schwarzschild MA, Spampinato U, Davidai G (2006) Novel pharmacological targets for the treatment of Parkinson's disease. Nature Rev 5:845-54
36. Shi C, Daly JW (1999) Chronic effects of xanthines on levels of central receptors in mice. Cell Mol Neurobiol 19:719-32
37. Soto J, Sacristan JA, Alsar MJ (1994) Cerebrospinal fluid concentrations of caffeine following oral drug administration: correlation with salivary and plasma concentrations. Ther Drug Monit 16:108-10
38. Strong R, Grotta JC, Aronowski J (2000) Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Neuropharmacology 39:515-22
39. Sutherland GR, Peeling J, Lesiuk HJ, Brownstone RM, Rydzy M, Saunders JK, Geiger JD (1991) The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience 42:171-82
40. Tan EK, Tan C, Fook-Chong SM, Lum SY, Chai A, Chung H, Shen H, Zhao Y, Teoh ML, Yih Y, Pavanni R, Chandran VR, Wong MC (2003) Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci 216:163-7
41. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C (2004) A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 24:1521-9
42. Varma MR, Dixon CE, Jackson EK, Peters GW, Melick JA, Griffith RG, Vagni VA, Clark RSB, Jenkins LW, Kochanek PM (2002) Administration of adenosine receptor agonists or antagonists after controlled cortical impact in mice: effects on function and histopathology. Brain Res 951:191-201
43. Yu L, Huang Z, Mariani J, Wang Y, Moskowitz M, Chen JF (2004) Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med 10:1044-5